A protein called myostatin limits muscle growth by blocking the creation of new muscle cells. When the gene for myostatin is removed in animals, muscle mass doubles because both the number and size of muscle cells increase.
See the scientific wording
Myostatin (MSTN), a member of the TGF-β superfamily, negatively regulates skeletal muscle mass by repressing myoblast proliferation and differentiation. Genetic knockout of MSTN results in a doubled muscle phenotype due to both hyperplasia and hypertrophy of muscle cells.
Indication only — weak evidence
One low-scoring study points this way, but the evidence is still early.
What the research says
1 study reviewedSupporting (1)
Narrative ReviewReview2025
This study shows that blocking myostatin helps people keep more muscle while losing weight, which supports the idea that myostatin normally limits muscle growth.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Myostatin is a protein that tells muscle cells to stop growing. When it is removed (like in genetic knockout), muscle cells receive more growth signals, so they grow bigger and multiply more, leading to much larger muscles.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
A protein called myostatin limits muscle growth by blocking the creation of new muscle cells. When the gene for myostatin is removed in animals, muscle mass doubles because both the number and size of muscle cells increase.
Mechanism
1 studyMyostatin normally tells muscle cells to stop growing. Removing myostatin (like in genetic knockout) takes away that stop signal, so muscle cells keep dividing and growing bigger, leading to muscles that are twice as large. This happens because the cells inside the muscles multiply more and each cell gets larger.
Myostatin is a protein that tells muscle cells to stop growing. When it is removed (like in genetic knockout), muscle cells receive more growth signals, so they grow bigger and multiply more, leading to much larger muscles.
Myostatin binds to activin type II receptors (ActRIIA/B) on skeletal muscle cells, recruiting and activating type I receptors (ALK4/5), leading to phosphorylation of SMAD2/3.
Phosphorylated SMAD2/3 forms a complex with SMAD4, translocates to the nucleus, and represses gene expression that promotes myoblast proliferation, differentiation, and fusion.
Inhibition of myostatin (e.g., by genetic knockout or neutralizing antibodies) prevents its binding to ActRIIA/B, blocking SMAD2/3 phosphorylation and downstream repression of myogenesis.
Removal of myostatin negative regulation allows increased myoblast proliferation and differentiation, leading to muscle fiber hyperplasia (more fibers) and hypertrophy (larger fibers), resulting in doubled muscle mass.
Less supported by current evidence, but not ruled out
Both myostatin and another similar protein called activin A stop muscle growth. Blocking both simultaneously removes more brakes on muscle growth than blocking myostatin alone, leading to even bigger muscles.
Both myostatin and activin A bind to activin type II receptors (ActRIIA/B) on muscle cells, initiating SMAD2/3 signaling that suppresses muscle growth.
Simultaneous blockade of myostatin (via anti-myostatin antibodies) and activin A (via anti-activin A antibodies) prevents both ligands from activating ActRIIA/B, removing negative regulation on muscle hypertrophy.
Dual blockade leads to greater muscle mass increase than single inhibition due to additive relief of SMAD2/3-mediated repression.
Evidence from Studies
Supporting (1)
Community contributions welcome
This study shows that blocking myostatin helps people keep more muscle while losing weight, which supports the idea that myostatin normally limits muscle growth.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
Clinical support requires direct evidence. Mechanistic proxy and tangential studies contribute only to the mechanistic score.
- All linked studies are tangential or mechanistic proxies — no direct test of the claim has been found.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Myostatin Knockout Studies Across Species
Comprehensive search and meta-analysis of all published animal (mouse, dog, sheep, cattle) and human studies with MSTN null mutations, including measures of muscle mass, fiber number (hyperplasia), and fiber size (hypertrophy).
Long-Term Cohort Study of Humans with Myostatin Gene Mutations
Prospective cohort following individuals with confirmed loss-of-function MSTN mutations (e.g., Belgian Blue-like phenotype in humans) compared to matched wild-type controls, measuring muscle mass via DXA, strength, and muscle biopsies over 5-10 years.
Case-Control Study of Myostatin Mutation Carriers versus Non-Carriers
Retrospective or nested case-control study comparing muscle mass and strength in individuals with MSTN mutations (cases) versus age-, sex-, and activity-matched controls without mutations, using imaging and biopsy to assess hyperplasia and hypertrophy.
Controlled Myostatin Knockout Mouse Study with Muscle Phenotyping
Randomized controlled experiment in mice: MSTN knockout vs wild-type littermates; assess muscle mass, fiber number, fiber cross-sectional area, and myoblast proliferation markers at multiple timepoints.